{"product_id":"lorenzos-oil-e6-b4-9b-e4-bc-a6s-oil-e6-b4-9b-e4-bc-a6-loren","title":"Fabiflu Favipiravir","description":"Favipiravir: A new and emerging antiviral option in COVID-19.\r\n\r\nDiscovered by Toyama Chemical Co., Ltd. in Japan, favipiravir is a modified pyrazine analog that was initially approved for therapeutic use in resistant cases of influenza. The antiviral targets RNA-dependent RNA polymerase (RdRp) enzymes, which are necessary for the transcription and replication of viral genomes. Not only does favipiravir inhibit replication of influenza A and B, but the drug has shown promise in the treatment of avian influenza, and may be an alternative option for influenza strains that are resistant to neuramidase inhibitors. Favipiravir has been investigated for the treatment of life-threatening pathogens such as Ebola virus, Lassa virus, and now COVID-19.\r\n\r\n\u003cstrong\u003eReference resources:\u003c\/strong\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003e《\u003ca href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1201971220322736\"\u003eRole of favipiravir in the treatment of COVID-19\u003c\/a\u003e》\u003c\/li\u003e\r\n \t\u003cli\u003e《\u003ca href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8159019\/\"\u003eFavipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis\u003c\/a\u003e》\u003c\/li\u003e\r\n \t\u003cli\u003e《\u003ca href=\"https:\/\/www.nature.com\/articles\/s41598-021-90551-6\"\u003eThe efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials\u003c\/a\u003e》\u003c\/li\u003e\r\n\u003c\/ul\u003e","brand":"Glenmark","offers":[{"title":"Default Title","offer_id":44797944889387,"sku":"Covid-19-001","price":25.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/2021-08-1381.png?v=1787022043","url":"https:\/\/xomeds.com\/products\/lorenzos-oil-e6-b4-9b-e4-bc-a6s-oil-e6-b4-9b-e4-bc-a6-loren","provider":"XOMEDS","version":"1.0","type":"link"}